Synthesis and characterization of d 5 -barbarin for use in barbarin-related research.

Autor: Kudrimoti S; The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA., Machin J; The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA., Arojojoye AS; Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA., Awuah SG; Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.; Center for Pharmaceutical Research and Innovation, College of Pharmacy and Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA., Eisenberg R; Frontier BioPharm, LLC, Richmond, Kentucky, USA., Fenger C; Equine Integrated Medicine, Georgetown, Kentucky, USA., Maylin G; New York Drug Testing and Research Program, Ithaca, New York, USA., Lehner AF; Veterinary Diagnostic Lab Section of Toxicology, Michigan State University, Lansing, Michigan, USA., Tobin T; The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.
Jazyk: angličtina
Zdroj: Drug testing and analysis [Drug Test Anal] 2023 Jan; Vol. 15 (1), pp. 42-46. Date of Electronic Publication: 2022 Aug 23.
DOI: 10.1002/dta.3357
Abstrakt: Based on structural similarities and equine administration experiments, Barbarin, 5-phenyl-2-oxazolidinethione from Brassicaceae plants, is a possible source of equine urinary identifications of aminorex, (R,S)-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine, an amphetamine-related US Drug Enforcement Administration (DEA) controlled substance considered illegal in sport horses. We now report the synthesis and certification of d 5 -barbarin to facilitate research on the relationship between plant barbarin and such aminorex identifications. D 5 -barbarin synthesis commenced with production of d 5 -2-oxo-2-phenylacetaldehyde oxime (d 5 -oxime) from d 5 -acetophenone via butylnitrite in an ethoxide/ethanol solution. This d 5 -oxime was then reduced with lithium aluminum hydride (LiAlH 4 ) to produce the corresponding d 5 -2-amino-1-phenylethan-1-ol (d 5 -phenylethanolamine). Final ring closure of the d 5 -phenylethanolamine was performed by the addition of carbon disulfide (CS 2 ) with pyridine. The reaction product was purified by recrystallization and presented as a stable white crystalline powder. Proton NMR spectroscopy revealed a triplet at 5.88 ppm for one proton, a double doublet at 3.71 ppm for one proton, and double doublet at 4.11 ppm for one proton, confirming d 5 -barbarin as the product. Further characterization by high resolution mass spectrometry supports the successful synthesis of d 5 -barbarin. Purity of the recrystallized product was ascertained by High Performance Liquid Chromatography (HPLC) to be greater than 98%. Together, we have developed the synthesis and full characterization of d 5 -barbarin for use as an internal standard in barbarin-related and equine forensic research.
(© 2022 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: